# Solid Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/solid-biosciences

- Industry: Biotechnology
- Headquarters: US
- Website: www.solidbio.com
- Total disclosed funding: $93M
- Latest round: Series C (Mar 30, 2017)
- Investors on record: 9

## About

Founded in 2013 and based in Massachusetts, US, Solid Biosciences Inc. operates as a biotechnology company that develops novel treatments for patients with Duchenne muscular dystrophy.

## Funding rounds

- Series C, Mar 30, 2017, $50M — Bain Capital, Leerink Partners, Foresite Capital, RTW Investments, RA Capital Management, Cormorant Asset Management, Janus Henderson Investors, Perceptive Advisors, Biogen
- Series B, Nov 3, 2015, $43M — Janus Henderson Investors, Perceptive Advisors, Biogen

## Investors

- Janus Henderson Investors — Series B, Series C
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series B, Series C
- Biogen — Series B, Series C
- Bain Capital (https://capitalatlas.ai/funds/bain-capital) — Series C
- Leerink Partners — Series C
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series C
- RTW Investments (https://capitalatlas.ai/funds/rtw-investments) — Series C
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series C
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series C